Shire plc, a leading biotechnology company focused on serving individuals with rare diseases, will present research covering a broad range of rare bleeding disorders at the 26th Biennial International Society on Thrombosis and Haemostasis Congress (ISTH), July 8-13, 2017 in Berlin, Germany.

https://www.shire.com/en/newsroom/2017/june/brdbz4

Share this story, choose your platform!